[Diabetes half-way between type 1 and type 2. LADA--the second biggest diabetic group where best treatment is uncertain].
Björklund
Anneli
A
Endokrinologiska kliniken, Karolinska Universitetssjukhuset Solna. anneli.bjorklund@ki.se
Grill
Valdemar
V
Carlsson
Sofia
S
Groop
Leif
L
D000328:Adult; D001327:Autoimmune Diseases / Q000175:diagnosis*; D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D010641:Phenotype
D007004:Hypoglycemic Agents; D007328:Insulin